Shenzhen Neptunus Bioengineer operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Neptunus Bioengineer with three other
companies in this sector in China:
Shanghai Fosun Pharmaceutical (Group) Company Limited
sales of 12.50 billion Chinese Renmimbi [US$1.86 billion]
of which 71%
was Pharmaceutical Manufacturing and R&D),
Humanwell Healthcare Group Co Ltd
(10.05 billion Chinese Renmimbi [US$1.49 billion]
of which 99%
was Medication & Health Products), and
Beijing Tongrentang Co., Ltd.
(10.79 billion Chinese Renmimbi [US$1.60 billion]
of which 51%
During the year ended December of 2015, sales at
Shenzhen Neptunus Bioengineer were 11.12 billion Chinese Renmimbi (US$1.65 billion).
increase of 13.4%
versus 2014, when the company's sales were 9.80 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shenzhen Neptunus Bioengineer
(and since 2010, sales have increased a total of 178%).
Sales of Other Operating saw an increase
that was more than double the company's growth rate: sales were up
106.6% in 2015, from
17.14 million Chinese Renmimbi to 35.40 million Chinese Renmimbi.
Shenzhen Neptunus Bioengineer also saw significant increases in sales in
Pharmaceutical Appliance (up 37.9% to 645.61 million Chinese Renmimbi)
Not all segments of Shenzhen Neptunus Bioengineer experienced an increase in sales in 2015:
sales of Pharmaceutical Manufacturing fell 27.9% to 477.68 million Chinese Renmimbi.